These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31302169)

  • 1. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
    Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
    Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
    Ramalingam P; Ko YT
    Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
    Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
    Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
    Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
    Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
    J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
    Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
    J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
    Ramalingam P; Ko YT
    Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated gene delivery by folate-poly(ethylene glycol)-grafted-trimethyl chitosan in vitro.
    Zheng Y; Song X; He G; Cai Z; Zhou Y; Yu B; Xu J; Wei Y; Hou S
    J Drug Target; 2011 Sep; 19(8):647-56. PubMed ID: 20964597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
    Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
    Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.